Eli Lilly and Statistics
Share Statistics
Eli Lilly and has 949.32M shares outstanding. The number of shares has increased by 0.12% in one year.
| Shares Outstanding | 949.32M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 897.26M |
| Failed to Deliver (FTD) Shares | 40.41K |
| FTD / Avg. Volume | 1.1% |
Short Selling Information
The latest short interest is 6.62M, so 0.7% of the outstanding shares have been sold short.
| Short Interest | 6.62M |
| Short % of Shares Out | 0.7% |
| Short % of Float | 0.78% |
| Short Ratio (days to cover) | 2.21 |
Valuation Ratios
The PE ratio is 100.5 and the forward PE ratio is 36.14. Eli Lilly and's PEG ratio is 0.31.
| PE Ratio | 100.5 |
| Forward PE | 36.14 |
| PS Ratio | 15.43 |
| Forward PS | 13 |
| PB Ratio | 48.89 |
| P/FCF Ratio | -167.09 |
| PEG Ratio | 0.31 |
Enterprise Valuation
Eli Lilly and has an Enterprise Value (EV) of 547.14B.
| EV / Earnings | 104.41 |
| EV / Sales | 16.03 |
| EV / EBITDA | 63.86 |
| EV / EBIT | 52.99 |
| EV / FCF | -173.59 |
Financial Position
The company has a current ratio of 0.94, with a Debt / Equity ratio of 2.34.
| Current Ratio | 0.94 |
| Quick Ratio | 0.73 |
| Debt / Equity | 2.34 |
| Total Debt / Capitalization | 70.08 |
| Cash Flow / Debt | 0.17 |
| Interest Coverage | 21.25 |
Financial Efficiency
Return on equity (ROE) is 0.49% and return on capital (ROIC) is 22.87%.
| Return on Equity (ROE) | 0.49% |
| Return on Assets (ROA) | 0.08% |
| Return on Capital (ROIC) | 22.87% |
| Revenue Per Employee | 793.58K |
| Profits Per Employee | 121.87K |
| Employee Count | 43.00K |
| Asset Turnover | 0.53 |
| Inventory Turnover | 1.23 |
Taxes
| Income Tax | 1.31B |
| Effective Tax Rate | 0.2 |
Stock Price Statistics
The stock price has increased by 37.94% in the last 52 weeks. The beta is 0.43, so Eli Lilly and's price volatility has been higher than the market average.
| Beta | 0.43 |
| 52-Week Price Change | 37.94% |
| 50-Day Moving Average | 837.3 |
| 200-Day Moving Average | 838.59 |
| Relative Strength Index (RSI) | 42.14 |
| Average Volume (20 Days) | 3.67M |
Income Statement
In the last 12 months, Eli Lilly and had revenue of $34.12B and earned $5.24B in profits. Earnings per share was $5.8.
| Revenue | 34.12B |
| Gross Profit | 27.04B |
| Operating Income | 10.33B |
| Net Income | 5.24B |
| EBITDA | 8.57B |
| EBIT | 10.33B |
| Earnings Per Share (EPS) | 5.8 |
Balance Sheet
The company has $2.82B in cash and $25.23B in debt, giving a net cash position of -$22.41B.
| Cash & Cash Equivalents | 2.82B |
| Total Debt | 25.23B |
| Net Cash | -22.41B |
| Retained Earnings | 10.31B |
| Total Assets | 75.61B |
| Working Capital | 6.74B |
Cash Flow
In the last 12 months, operating cash flow was $4.24B and capital expenditures -$7.39B, giving a free cash flow of -$3.15B.
| Operating Cash Flow | 4.24B |
| Capital Expenditures | -7.39B |
| Free Cash Flow | -3.15B |
| FCF Per Share | -3.49 |
Margins
Gross margin is 79.25%, with operating and profit margins of 30.26% and 15.36%.
| Gross Margin | 79.25% |
| Operating Margin | 30.26% |
| Pretax Margin | 19.21% |
| Profit Margin | 15.36% |
| EBITDA Margin | 25.11% |
| EBIT Margin | 30.26% |
| FCF Margin | -9.24% |
Dividends & Yields
LLY pays an annual dividend of $6, which amounts to a dividend yield of 0.77%.
| Dividend Per Share | $6.00 |
| Dividend Yield | 0.77% |
| Dividend Growth (YoY) | 32.74% |
| Payout Ratio | 64.45% |
| Earnings Yield | 0.74% |
| FCF Yield | -0.42% |
Analyst Forecast
The average price target for LLY is $1000, which is 26.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $1000 |
| Price Target Difference | 26.7% |
| Analyst Consensus | Buy |
| Analyst Count | 28 |
Stock Splits
The last stock split was on Oct 16, 1997. It was a forward split with a ratio of 2:1.
| Last Split Date | Oct 16, 1997 |
| Split Type | forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | 8.77 |
| Piotroski F-Score | 5 |